Hepatology
News
New Drugs Trump Interferon in HCV Therapy
Major finding: In a phase II study 100% of treatment naive patients with hepatitis C genotype 1 had an SVR12 with once-daily combination pill....
News
The Price and Cost of Hepatitis C Treatment
News
Drug Combo Effective in Resistant Hepatitis C
Major finding: A total of 98% of patients with chronic HCV 1 and 91% of those with chronic HCV 2 or 3 achieved a sustained virologic response on...
News
Once-a-day HCV Protease Inhibitor Approved for Treating Hepatitis C
News
Boceprevir, Telaprevir Linked to Anemia in HCV-infected Seniors
Major finding: Sixteen of 17 patients aged 65 years or older treated with boceprevir experienced anemia. Data source: A 1,100-patient subset of...
News
ECHO Model Cost-effective for HCV
Major finding: The ECHO model for treating hepatitis C is cost saving in 35% of patients and very cost effective overall. Data source: A...
News
Interferon-free Oral Regimen Effective in Hepatitis C, HIV Coinfected
Major finding: Treatment with sofosbuvir and ribavirin resulted in SVR12 rates of 76%, 88%, and 67%, for those infected with HIV and HCV genotypes...
News
How to Manage Anemia From HCV Treatment
Major finding: In a study of 500 patients with chronic hepatitis C patients who developed anemia while on triple therapy, the sustained virologic...